Nalaganje...

Induction of HLA-DP4-restricted anti-Survivin Th1 and Th2 responses using an artificial antigen-presenting cell

PURPOSE: In previous cancer vaccine clinical trials targeting Survivin, induction of specific CD8(+) T cell responses did not consistently lead to clinical responses. Considering the critical role of CD4(+) T cell help in generating anti-tumor immunity, integration of anti-Survivin CD4(+) T cell res...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tanaka, Makito, Butler, Marcus O., Ansén, Sascha, Imataki, Osamu, Berezovskaya, Alla, Nadler, Lee M., Hirano, Naoto
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3156899/
https://ncbi.nlm.nih.gov/pubmed/21705450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-3083
Oznake: Označite
Brez oznak, prvi označite!